Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.410
+0.010 (0.71%)
Mar 28, 2024, 11:54 AM EDT - Market open

Cyclo Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1996
Revenue
1.081.381.590.91.011.011.241.50.951.57
Upgrade
Revenue Growth (YoY)
-21.76%-13.24%75.54%-10.31%-0.42%-18.28%-17.64%58.13%-39.36%-7.43%
Upgrade
Cost of Revenue
0.080.140.160.070.080.110.130.20.120.27
Upgrade
Gross Profit
0.991.241.430.840.930.911.11.30.831.29
Upgrade
Selling, General & Admin
4.95.415.053.152.881.631.742.071.811.18
Upgrade
Research & Development
14.1899.156.14.872.712.291.860.660.09
Upgrade
Other Operating Expenses
1.962.451.510.550.730.830.911.570.770.59
Upgrade
Operating Expenses
21.0416.8615.729.88.485.174.955.513.231.86
Upgrade
Operating Income
-20.05-15.62-14.29-8.96-7.54-4.27-3.84-4.21-2.41-0.56
Upgrade
Interest Expense / Income
00000000.030.030.03
Upgrade
Other Expense / Income
0.01-0.17-0-0.02-0.01-0.01-0.01-0.01-0.01-0
Upgrade
Pretax Income
-20.06-15.45-14.29-8.94-7.53-4.26-3.83-4.22-2.43-0.59
Upgrade
Income Tax
000000000.120
Upgrade
Net Income
-20.06-15.45-14.29-8.94-7.53-4.26-3.83-4.22-2.55-0.59
Upgrade
Shares Outstanding (Basic)
16862111111
Upgrade
Shares Outstanding (Diluted)
16862111111
Upgrade
Shares Change
93.50%32.48%298.32%47.81%32.33%13.49%13.70%12.71%11.21%35.99%
Upgrade
EPS (Basic)
-1.23-1.83-2.24-5.60-6.97-5.00-5.00-7.00-5.00-1.00
Upgrade
EPS (Diluted)
-1.23-1.83-2.24-5.60-6.97-5.00-5.00-7.00-5.00-1.00
Upgrade
Free Cash Flow
-16.19-15.13-15.03-8.59-6.59-3.19-3.06-2.04-2.41-0.81
Upgrade
Free Cash Flow Per Share
-0.99-1.79-2.36-5.37-6.09-3.90-4.25-3.21-4.28-1.59
Upgrade
Gross Margin
92.16%89.90%90.16%92.65%92.50%89.62%89.26%86.80%86.91%82.61%
Upgrade
Operating Margin
-1862.69%-1135.51%-901.15%-991.99%-749.06%-421.84%-310.51%-279.85%-253.22%-35.87%
Upgrade
Profit Margin
-1863.36%-1123.08%-900.94%-989.80%-747.87%-420.68%-309.68%-281.04%-268.44%-37.81%
Upgrade
Free Cash Flow Margin
-1503.84%-1099.71%-947.67%-951.24%-654.37%-315.52%-247.60%-135.44%-253.35%-51.36%
Upgrade
EBITDA
-20.04-15.43-14.27-8.93-7.53-4.24-3.82-4.09-2.23-0.41
Upgrade
EBITDA Margin
-1861.57%-1121.66%-899.88%-988.39%-747.31%-419.67%-308.93%-272.02%-234.73%-25.94%
Upgrade
Depreciation & Amortization
0.020.020.020.010.010.010.010.110.170.15
Upgrade
EBIT
-20.06-15.45-14.29-8.94-7.53-4.26-3.83-4.2-2.4-0.56
Upgrade
EBIT Margin
-1863.36%-1123.08%-900.94%-989.80%-747.87%-420.68%-309.68%-279.14%-252.52%-35.66%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).